Reports
Reports
Sale
The global optical genome mapping market size is anticipated to grow at a CAGR of 19.7% during the forecast period of 2024-2032, driven by the increasing accessibility and affordability of technology in the field across the globe.
Optical genome mapping is an innovative technology which enables the comprehensive analysis and mapping of the entire genome of an organism. Optical genome mapping (OGM) images extra-long linear, and single DNA molecules (median size > 250 kb) that are labeled at certain locations. This tedious technique has been updated by Bionano Genomics and is now popular as “optical mapping for structural variation analysis by whole-genome mapping.
Optical genome mapping allows researchers and scientists to study genetic differences, structural rearrangements, and other genomic alterations with high accuracy and resolution. Optical genome mapping provides valuable insights into genomic disorders, cancer research, personalized medicine, and other fields of genomics.
The continuous advancements in technology is leading to improved efficiency, accuracy, and scalability of the optical genome mapping platforms, resulting in optical genome mapping market growth. The development in optical genome mapping platforms has enabled faster and more cost-effective genome mapping, making it more accessible to researchers and clinicians. The increasing use of optical genome mapping platforms to detect and analyze genetic abnormalities related to several diseases and disorders is taking place. It provides a detailed view of the genome, allowing for the identification of structural differences.
Market Breakup by Product
Market by Application
Market by End User
Market Breakup by Region
The rapid advancements in genomics research, increasing demand for personalized medicine, and the need for detailed genomic analysis are some of the key factors which are aiding the optical genome mapping market expansion. Optical genome mapping technologies have been revolutionizing the way studies were done in order to understand genome, providing high-resolution mapping of genomic versions and structural dislocations. These technologies have discovered uses in several areas, including clinical diagnostics, pharmaceutical research, and agriculture.
The market for optical genome mapping is expected to grow due to the increased accessibility and affordability of technology in the field. Growing advancements in equipment design, automation, and data analysis algorithms are making optical genome mapping platforms more user-friendly and efficient. Due to this factor, the integration of optical genome mapping platforms is done in research and clinical workflows in order to achieve faster and more accurate analysis of genomic data.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Optical Genome Mapping Market Overview
3.1 Global Optical Genome Mapping Market Historical Value (2017-2023)
3.2 Global Optical Genome Mapping Market Forecast Value (2024-2032)
4 Global Optical Genome Mapping Market Landscape
4.1 Global Optical Genome Mapping Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Optical Genome Mapping Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Global Optical Genome Mapping Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Optical Genome Mapping Market Segmentation
6.1 Global Optical Genome Mapping Market by Product
6.1.1 Market Overview
6.1.2 Consumables
6.1.3 Instruments
6.2 Global Optical Genome Mapping Market by Application
6.2.1 Market Overview
6.2.2 Genome Assembly
6.2.3 Structural Variation Detection
6.2.4 Microbial Strain Typing
6.2.5 Haplotype Phasing
6.2.6 Others
6.3 Global Optical Genome Mapping Market by End User
6.3.1 Market Overview
6.3.2 Research and Academic Institutions
6.3.3 Biotechnology and Pharmaceutical Companies
6.3.4 Clinical Laboratories
6.3.5 Others
6.4 Global Optical Genome Mapping Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Optical Genome Mapping Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Optical Genome Mapping Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Optical Genome Mapping Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Optical Genome Mapping Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Optical Genome Mapping Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Bionano Genomics, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Nucleome Informatics Pvt Ltd
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 PerkinElmer, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Nabsys Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 France Génomique
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Praxis Genomics LLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 OpGen, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Thermo Fisher Scientific, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Illumina, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 HemoCue Holding AB
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Optical Genome Mapping Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market is anticipated to grow at a CAGR of 19.7% during the forecast period of 2024-2032, driven by the rising attempts by healthcare facilities to reduce their expenditures.
The growth of the market is driven by factors like the increasing demand for personalized medicine and the need for detailed genomic analysis.
The key trends for the market include the increasing use of optical genome mapping platforms to detect and analyze genetic abnormalities related to several diseases and disorders.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The different types of products in the market are consumables and instruments.
The product finds wide applications in genome assembly, structural variation detection, microbial strain typing, and haplotype phasing, among others.
The different types of end users in the optical genome market are research and academic institutions, biotechnology and pharmaceutical companies, and clinical laboratories, among others.
Key players involved in the market are Bionano Genomics, Inc., Nucleome Informatics Pvt Ltd, PerkinElmer, Inc., Nabsys Inc., Praxis Genomics LLC, OpGen, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., HemoCue Holding AB., and France Génomique.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.